MONDAY, OCTOBER 23, 2017

Early antiretroviral therapy avoids AIDS outcomes for HIV-infected people

A study recently showed that receiving early antiretroviral therapy helps to prevent serious AIDS-related diseases as well as the onset of cardiovascular disease, cancer and many other health issues for people with HIV infections. Read More »

Adjuvants increase immune response for H7N9 flu vaccine

A team of scientists from The Wistar Institute recently found a specific set of mutations within influenza that has adapted to avoid the traditional vaccine design, making adjuvants more valuable in improving the immune response to vaccines like the H7N9 flu vaccine. Read More »

21st Century Cures Act risks public health

According to the National Vaccine Information Center (NVIC), a nonprofit organization, the proposed H4 6 or 21st Century Cures Act places public health at risk by lowering the licensing standards of the U.S. Federal Drug Administration (FDA). Read More »

New financing pumps up SutroVax vaccine plans

SutroVax Inc., a relatively new biopharmaceutical vaccine company, has completed a $22 million Series A financing deal that will allow the Sutro Biopharma spinoff to develop vaccines for infectious disease targets. Read More »

TSRI scientist receives Gates Foundation grants for AIDS vaccine

A researcher from The Scripps Research Institute (TSRI) recently received two grants amounting to $4.5 million from the Bill & Melinda Gates Foundation in order to develop an HIV/AIDS vaccine. Read More »

WHO encourages proactive measures to control hepatitis

As part of World Hepatitis Day on July 28, the World Health Organization (WHO) emphasized the desperate need for proactive measures to prevent viral hepatitis infections around the world. Read More »

Diagnostic test created for enterovirus D68

Scientists at Washington University School of Medicine in St. Louis, Missouri, recently created a diagnostic test that rapidly detects enterovirus D68 (EV-D68), which is a respiratory virus. Read More »

Study: Mowing dry basins can boost mosquito activity, West Nile risk

A recent University of Illinois study on the risk of West Nile virus with “dry” water-detention basins in Central Illinois indicated that mowing these dry basins worsens mosquito problems. The researchers said mowing wetland plants inside basins that have not properly drained can cause a rapid increase in Culex pipiens mosquito populations, which can carry and transmit West Nile virus. Read More »

FDA announces 2014 Food Safety Challenge winners

The U.S. Food and Drug Administration (FDA) on Wednesday announced the 2014 FDA Food Safety Challenge winners in a competition to advance breakthrough ideas on detecting disease-causing organisms in food. Read More »

Microbiome study suggests “it takes a village” of bacteria to protect against infections

Like the saying “it takes a village,” the variety and mixture of bacteria that thrives inside the human gut may unite to protect humans against dangerous infections, a University of Michigan (UM) Medical School study published Thursday in mBios indicates. Read More »

U.S.-Cuba vaccine partnership focused on clinical trials

New York and Havana researchers are working together on cancer vaccines and getting ready for clinical trials. Read More »

Amish Measles contained via vaccination strategy

In 2014, the highest number of reported measles cases in the U.S. spread through the North American Amish communities in Ohio, and it could have been much worse if it were not for vaccinations. Read More »

PaxVax and Valneva team to market and distribute travel vaccines

Valneva and PaxVax Inc. announced Thursday they have entered into a marketing and distribution agreement for their cholera and typhoid vaccines. Read More »

Measles may target immune memory cells, according to report

Measles infections may leave your body weaker than previously thought, according to new research published in the Science Journal. Read More »

New England Journal of Medicine reports on PMO-based therapeutic

On Wednesday, the New England Journal of Medicine published clinical data for AVI-7288, a PMO-plus antisense oligonucleotide, demonstrating the drug's safety. Read More »

Study: Both empirical, theoretical approaches needed to create AIDS vaccine

The National Institute of Allergy and Infections Diseases (NIAID), under the National Institutes of Health, looked back at the history of efforts to develop a preventive HIV vaccine. The two approaches to seek out a cure provide insights into the disease. Read More »

Hepatitis B and C tests can save lives

The European Centre for Disease Prevention and Control (ECDC) said Monday that approximately 50,000 people are diagnosed with hepatitis B and C each year, potentially saving their lives, but millions remain unaware that they have hepatitis B and C infections. Read More »

Florida Department of Health warns residents against West Nile virus

Woman in Walton County is state's first human case of the disease for 2015. Read More »

GlaxoSmithKline malaria candidate vaccine receives positive reviews

Mosquirix, the malaria candidate from GlaxoSmithKline, recently received positive feedback from regulators in Europe about the malaria prevention rates in young children who live in sub-Saharan Africa. Read More »

Abbott improves managing TB and multidrug-resistant TB

Abbott Laboratories recently said its RealTime MTB and  RealTime MTB RIF/INH Resistance assays improve the management of tuberculosis and multidrug-resistant TB (MDR-TB). Read More »